The Aperlena Verdict
Open raceNo supplier dominates: 109 different companies have won the last 144 comparable contracts from this buyer over 5 years. This is a genuinely open race.
Based on 144 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThe purchaser in Estonia is buying medicines including antineoplastic agents, immunosuppressants, medicines used in ophthalmology, medicines for the treatment of obstructive airway diseases and antimigraine medicines. The procurement lists purchases of medicines by active substance, naming panitumumab, gemtuzumab ozogamicin, brentuximab vedotin, pertuzumab, trastuzumab emtansine, obinutuzumab, nivolumab, pembrolizumab, blinatumomab, daratumumab, durvalumab, atezolizumab and cemiplimab, among others. Exclusion grounds and qualification conditions are set out in the procurement documents. Interested suppliers should consult the underlying procurement documents for the full requirements relating to each active substance.
Description
Bid or no-bid?
Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.
Can I bid?
- Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
- The notice is written in Estonian.
- Certificates from another EU country? Check the equivalents on eCertis
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 day ago
What this buyer has paid before
Based on 14 comparable contracts this buyer awarded in this sector over the last 4 years.
- This notice
- €26.5M
- Median award
- €313,782
- Middle half of past awards
- €124,011 to €437,760
The estimate is larger than three in four past awards.
Most recent awards
- Medicines - Hospital medicines - September 2026 €415,814
- Medicines - Hospital medicines - August 2026 €1,028,369
- Eesti - Ravimid - 311832 Haiglaravimid - juuni 2026 2 €316,036
- Eesti - Ravimid - Haiglaravimid - juuni 2026 €24,418
- Eesti - Ravimid - Haiglaravimid - aprill 2026 €311,528
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profilesihtasutus Põhja-Eesti Regionaalhaigla
- notices in the register
- 453
- awards
- 225
- awarded in total
- €16.6M
Who wins its contracts
Many suppliers- different companies won its awards
- 158
- of the awards went to the three most frequent winners
- 6%
- of its calls state an estimated value
- 93%
Based on 199 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.8
- of those lots received a single tender
- 39%
- of the awards went to companies based in another country
- 13%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| AB Medical Group Eesti osaühing | 4 | Mar 2026 | |
| AKTSIASELTS MEDITSIINIGRUPP | 4 | Dec 2025 | |
| Quantum Eesti AS | 4 | Aug 2026 | |
| Abbott Medical Estonia OÜ | 3 | Jun 2026 | |
| aktsiaselts SEMETRON | 3 | Jun 2026 |
Based on 144 awards with a linked company profile over the last 5 years.
5 open tenders right now
- Medical devices - Neuronavigation system 2 days left
- Snow clearing services - Snow clearing service 5 days left
- Medical devices - Neuronavigation system 15 days left
Market context
Larger than 96% of the open notices in Medical equipment & pharmaceuticals across Europe.
- open now in Medical equipment & pharmaceuticals
- 11,052
- median open notice
- €143,235
Who wins in this market
Many suppliersEstonia · Medical equipment & pharmaceuticals
- different companies won awards here
- 346
- of the awards went to the three most frequent winners
- 13%
- buyers awarded contracts here
- 52
Based on 667 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.7
- of those lots received a single tender
- 36%
- of the awards went to companies based in another country
- 8%
- of the tenders came from another country
- 19%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
15
days left
€2,860,000
est. value
Open elsewhere in Europe
20
days left
€4,435,380
est. value
Matched by meaning across languages, from the notices' own words: the same kind of contract, open now in another country.
Awarded before
Never miss a tender like this
560 new notices in Medical equipment & pharmaceuticals in Estonia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert